A small molecule inhibitor of leucine carboxyl methyltransferase-1 inhibits cancer cell survival
Reversible phosphorylation is the basis for signal transduction in eukaryotic cells, and this is tightly controlled by the complex interplay of kinases and phosphatases. Many malignancies are characterized by dysregulation of the delicate protein phosphorylation balance. The targeting of protein pho...
Saved in:
Main Authors: | O. A. Arosarena (Author), A. S. Saribas (Author), E. P. Papadopoulos (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of Small Molecules as Membrane-Bound Catechol-<i>O</i>-methyltransferase Inhibitors with Interest in Parkinson's Disease: Pharmacophore Modeling, Molecular Docking and In Vitro Experimental Validation Studies
by: Pedro Cruz-Vicente, et al.
Published: (2021) -
Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer
by: Jiayi Shen, et al.
Published: (2024) -
Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells
by: Qiufen Zhang, et al.
Published: (2022) -
Glucocorticoid-Induced Leucine Zipper: A Novel Anti-inflammatory Molecule
by: Oxana Bereshchenko, et al.
Published: (2019) -
DNA methyltransferase inhibitor exposure-response: Challenges and opportunities
by: Amanda B. Kagan, et al.
Published: (2023)